Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis

Fig. 1

Estimated survival probability of multivariable Cox regression model with time-dependent corticosteroid treatment. Cox regression model with corticosteroid treatment was time-varying variable, adjusting for age, sex, SOFA score at hospital admission, propensity score of corticosteroid treatment, comorbidities (diabetes, hypertension, chronic pulmonary disease, chronic renal or liver disease, solid malignant tumor, hematologic malignancy, and immunosuppressive status), antiviral treatment (Lopinavir–Ritonavir, oseltamivir, and ganciclovir), and respiratory supports (high-flow oscillation oxygen, noninvasive mechanical ventilation, and invasive mechanical ventilation). Propensity score was calculated by a non-parsimonious logistic regression model that included: age, sex, SOFA score, temperature, respiratory rate, SpO2/FiO2 ratio, blood lymphocyte count, blood neutrophil count, and level of c-reactive protein at hospital admission. ARDS, acute respiratory distress syndrome; SOFA, sequential organ failure assessment

Back to article page